XGN
Exagen Inc.
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Last price
7.63
▼ 0.15 (1.91%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
7.81
Prev close
7.78
Day high
7.99
Day low
7.62
Volume
251.71K
Market cap
$191.86M
P/E (TTM)
—
52W range
2.59 – 12.23
Insider net activity
Net shares
+200.33K
Net buying
Buy transactions
3
229.05K shares
Sell transactions
3
28.71K shares
Net transactions
+6
Buys less sells
Sell : buy shares
0.1 : 1
Mixed
Insider-held shares
6.74M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Mar 12, 26 | BLACK JEFFREY G Chief Financial Officer |
STOCK | 76.51K | $241.65K | Direct |
| Mar 12, 26 | ABALLI JOHN Chief Executive Officer |
STOCK | 150.00K | $0 | Direct |
| Mar 3, 26 | ABALLI JOHN Chief Executive Officer |
STOCK | 2.54K | $7.80K | Direct |
| Mar 3, 26 | ABALLI JOHN Chief Executive Officer |
SELL | 15.70K | $56.83K | Direct |
| Feb 24, 26 | BLACK JEFFREY G Chief Financial Officer |
SELL | 1.58K | $5.72K | Direct |
| Feb 24, 26 | ABALLI JOHN Chief Executive Officer |
SELL | 11.43K | $41.26K | Direct |
| Oct 16, 25 | ABALLI JOHN Chief Executive Officer |
SELL | 31.79K | $375.60K | Direct |
| Sep 2, 25 | BLACK JEFFREY G Chief Financial Officer |
SELL | 20.47K | $200.36K | Direct |
| Mar 25, 25 | NMSIC CO-INVESTMENT FUND, L.P Beneficial Owner of more than 10% of a Class of Security |
SELL | 350.00K | $1.16M | Indirect |
| Feb 28, 25 | ABALLI JOHN Chief Executive Officer |
STOCK | 8.62K | $29.83K | Direct |
| Feb 21, 25 | BLACK JEFFREY G Chief Financial Officer |
STOCK | 15.00K | $0 | Direct |
| Feb 21, 25 | ABALLI JOHN Chief Executive Officer |
STOCK | 112.50K | $0 | Direct |
| Nov 20, 24 | NMSIC CO-INVESTMENT FUND, L.P Beneficial Owner of more than 10% of a Class of Security |
SELL | 200.00K | $840.00K | Indirect |
| Nov 15, 24 | BLACK JEFFREY G Chief Financial Officer |
BUY | 22.30K | $66.45K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ABALLI JOHN |
Chief Executive Officer | 880.24K | Stock Award(Grant) |
BLACK JEFFREY G |
Chief Financial Officer | 342.44K | Stock Award(Grant) |
NMSIC CO-INVESTMENT FUND, L.P |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.00
Call-heavy session
Put / call open interest
0.06
Positioning, not flow
Max pain
5.00
-36.9% from spot
ATM implied vol
75.8%
Nearest strike to spot
Skew (10% OTM)
+87.5%
Puts bid over calls
Call volume
11
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
5.00
52 contracts
Heaviest put OI
5.00
5 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
+18.92%
+20.3%
1M
+60.00%
+56.3%
3M
+85.48%
+82.4%
6M
+132.26%
+121.2%
YTD
+30.26%
+18.0%
1Y
-19.51%
-39.5%
3Y
+214.29%
+140.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$191.86M
Enterprise value$194.93M
Revenue (TTM)$71.12M
Gross profit$41.70M
EBITDA$-10.77M
Net income$-18.92M
EPS (TTM)$-0.82
Free cash flow$-1.56M
Total cash$24.59M
Total debt$27.66M
Book value / share$0.51
Shares outstanding24.23M
Float13.87M
Short % of float4.12%
Dividend yield—
Beta (5Y)2.03
Short interest
Shares short
903.88K
Prior 813.37K
Change vs prior
+11.1%
Shorts adding
% of float
4.12%
Normal
% of shares out
3.73%
Against total outstanding
Days to cover
4.1
Liquid
Float
13.87M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Valuation & profitability ratios
Trailing P/E—
Forward P/E-18.00
PEG ratio—
Price / sales—
Price / book15.68
EV / revenue2.74
EV / EBITDA-18.10
Gross margin58.64%
Operating margin-8.63%
Profit margin-26.61%
Return on equity-113.82%
Return on assets-14.92%
Debt / equity226.39
Current ratio3.19
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $66.58M | $55.64M | $52.55M | $45.56M | +19.7% |
| Operating revenue | $66.58M | $55.64M | $52.55M | $45.56M | +19.7% |
| Cost of revenue | $27.78M | $22.53M | $23.09M | $24.21M | +23.3% |
| Gross profit | $38.80M | $33.11M | $29.46M | $21.35M | +17.2% |
| Research & development | $6.25M | $5.38M | $4.87M | $9.88M | +16.4% |
| Selling, general & admin | $46.62M | $41.37M | $47.43M | $52.02M | +12.7% |
| Total operating expense | $52.87M | $46.75M | $52.29M | $61.89M | +13.1% |
| Operating income | -$14.07M | -$13.64M | -$22.84M | -$40.55M | -3.2% |
| Net interest income | -$4.03M | -$1.47M | -$819.00K | -$1.62M | -174.6% |
| Pre-tax income | -$19.90M | -$15.10M | -$23.66M | -$47.67M | -31.8% |
| Tax provision | $51.00K | $12.00K | $33.00K | -$282.00K | +325.0% |
| Net income | -$19.95M | -$15.12M | -$23.69M | -$47.39M | -32.0% |
| Net income to common | -$19.95M | -$15.12M | -$23.69M | -$47.39M | -32.0% |
| Basic EPS | -0.93 | -0.83 | -1.34 | -2.77 | -12.0% |
| Diluted EPS | -0.93 | -0.83 | -1.34 | -2.77 | -12.0% |
| EBIT | -$15.58M | -$12.87M | -$21.32M | -$45.22M | -21.1% |
| EBITDA | -$13.46M | -$11.14M | -$19.15M | -$43.66M | -20.8% |
| Basic shares | 21.56M | 18.20M | 17.68M | 17.08M | +18.4% |
| Diluted shares | 21.56M | 18.20M | 17.68M | 17.08M | +18.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $32.22M | $22.04M | $36.49M | $62.39M | — | +46.2% |
| Cash & short-term investments | $32.22M | $22.04M | $36.49M | $62.39M | — | +46.2% |
| Accounts receivable | $10.86M | $7.83M | $6.55M | $6.08M | — | +38.5% |
| Total current assets | $48.89M | $36.45M | $47.84M | $72.61M | — | +34.1% |
| Property, plant & equipment | $8.37M | $7.68M | $8.49M | $13.08M | — | +9.0% |
| Goodwill & intangibles | — | — | — | $0 | $5.51M | — |
| Total assets | $58.02M | $44.69M | $56.94M | $86.22M | — | +29.8% |
| Total current liabilities | $14.16M | $13.51M | $11.90M | $9.62M | — | +4.8% |
| Current debt | $643.00K | $423.00K | $264.00K | $190.00K | — | +52.0% |
| Long-term debt | $22.26M | $19.82M | $19.23M | $28.78M | — | +12.3% |
| Total debt | $25.71M | $23.21M | $23.23M | $35.20M | — | +10.8% |
| Total liabilities | $40.57M | $35.15M | $34.25M | $43.76M | — | +15.4% |
| Retained earnings | -$314.28M | -$294.33M | -$279.22M | -$255.53M | — | -6.8% |
| Shareholder equity | $17.45M | $9.54M | $22.69M | $42.46M | — | +82.9% |
| Working capital | $34.73M | $22.95M | $35.94M | $62.99M | — | +51.4% |
| Net tangible assets | $17.45M | $9.54M | $22.69M | $42.46M | — | +82.9% |
| Shares issued | 22.91M | 17.64M | 17.05M | 16.55M | — | +29.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$19.95M | -$15.12M | -$23.69M | -$47.39M | -32.0% |
| Depreciation & amortisation | $2.12M | $1.72M | $2.17M | $1.56M | +22.9% |
| Stock-based compensation | $2.16M | $1.76M | $3.62M | $4.70M | +22.4% |
| Change in working capital | -$1.98M | -$3.08M | $325.00K | $1.67M | +35.6% |
| Operating cash flow | -$13.63M | -$13.28M | -$14.46M | -$32.14M | -2.6% |
| Capital expenditure | -$641.00K | -$515.00K | -$828.00K | -$4.32M | -24.5% |
| Investing cash flow | -$626.00K | -$515.00K | -$804.00K | -$4.32M | -21.6% |
| Financing cash flow | $24.43M | -$663.00K | -$10.63M | -$489.00K | +3,785.5% |
| Free cash flow | -$14.27M | -$13.79M | -$15.29M | -$36.46M | -3.4% |
| End cash position | $32.42M | $22.24M | $36.69M | $62.59M | +45.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $19.94M | $17.31M | $16.63M | $17.24M | $17.20M | +15.2% |
| Operating revenue | $19.94M | $17.31M | $16.63M | $17.24M | $17.20M | +15.2% |
| Cost of revenue | $7.72M | $7.10M | $7.42M | $7.17M | $6.81M | +8.8% |
| Gross profit | $12.22M | $10.21M | $9.21M | $10.07M | $10.39M | +19.7% |
| Research & development | $1.43M | $1.55M | $1.76M | $1.73M | $1.48M | -8.2% |
| Selling, general & admin | $12.51M | $12.07M | $12.42M | $11.45M | $11.54M | +3.7% |
| Total operating expense | $13.94M | $13.62M | $14.18M | $13.18M | $13.03M | +2.3% |
| Operating income | -$1.72M | -$3.41M | -$4.97M | -$3.10M | -$2.63M | +49.6% |
| Net interest income | -$1.05M | -$1.40M | -$1.29M | -$1.32M | -$1.04M | +25.1% |
| Pre-tax income | -$3.20M | -$3.93M | -$4.66M | -$7.09M | -$4.40M | +18.7% |
| Tax provision | $0 | $36.00K | $13.00K | $1.00K | $37.00K | -100.0% |
| Net income | -$3.20M | -$3.97M | -$4.67M | -$7.09M | -$4.44M | +19.4% |
| Net income to common | -$3.20M | -$3.97M | -$4.67M | -$7.09M | -$4.44M | +19.4% |
| Basic EPS | -0.13 | -0.17 | -0.20 | -0.31 | -0.21 | +23.5% |
| Diluted EPS | -0.13 | -0.17 | -0.20 | -0.31 | -0.21 | +23.5% |
| EBIT | -$2.00M | -$2.66M | -$3.33M | -$5.77M | -$3.28M | +25.1% |
| EBITDA | -$1.37M | -$2.06M | -$2.73M | -$5.16M | -$2.81M | +33.8% |
| Basic shares | 24.16M | 23.85M | 23.58M | 22.94M | 21.09M | +1.3% |
| Diluted shares | 24.16M | 23.85M | 23.58M | 22.94M | 21.09M | +1.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $24.59M | $21.51M | $32.22M | $35.65M | $30.03M | +14.3% |
| Cash & short-term investments | $24.59M | $21.51M | $32.22M | $35.65M | $30.03M | +14.3% |
| Accounts receivable | $12.41M | $15.77M | $10.86M | $11.09M | $14.27M | -21.3% |
| Total current assets | $42.86M | $43.58M | $48.89M | $52.59M | $50.99M | -1.7% |
| Property, plant & equipment | $8.52M | $7.79M | $8.37M | $9.18M | $6.51M | +9.3% |
| Total assets | $51.94M | $51.96M | $58.02M | $62.82M | $58.76M | -0.0% |
| Total current liabilities | $13.46M | $12.56M | $14.16M | $12.89M | $10.29M | +7.1% |
| Current debt | $517.00K | $580.00K | $643.00K | $680.00K | $667.00K | -10.9% |
| Long-term debt | $22.32M | $22.29M | $22.26M | $22.26M | $22.31M | +0.1% |
| Total debt | $26.04M | $25.35M | $25.71M | $26.03M | $25.20M | +2.7% |
| Total liabilities | $39.72M | $37.52M | $40.57M | $44.69M | $37.73M | +5.8% |
| Retained earnings | -$321.44M | -$318.25M | -$314.28M | -$309.61M | -$302.52M | -1.0% |
| Shareholder equity | $12.22M | $14.43M | $17.45M | $18.14M | $21.03M | -15.4% |
| Working capital | $29.40M | $31.02M | $34.73M | $39.70M | $40.69M | -5.2% |
| Net tangible assets | $12.22M | $14.43M | $17.45M | $18.14M | $21.03M | -15.4% |
| Shares issued | 24.19M | 24.09M | 22.91M | 22.51M | 22.00M | +0.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$3.20M | -$3.97M | -$4.67M | -$7.09M | -$4.44M | +19.4% |
| Depreciation & amortisation | $628.00K | $599.00K | $600.00K | $612.00K | $466.00K | +4.8% |
| Stock-based compensation | $980.00K | $655.00K | $705.00K | $593.00K | $443.00K | +49.6% |
| Change in working capital | $4.57M | -$7.77M | $1.30M | $5.96M | -$1.12M | +158.8% |
| Operating cash flow | $3.99M | -$10.42M | -$3.01M | $2.94M | -$2.88M | +138.3% |
| Capital expenditure | -$543.00K | -$228.00K | -$44.00K | -$275.00K | -$209.00K | -138.2% |
| Investing cash flow | -$543.00K | -$228.00K | -$35.00K | -$275.00K | -$209.00K | -138.2% |
| Financing cash flow | -$370.00K | -$62.00K | -$384.00K | $2.95M | $21.93M | -496.8% |
| Free cash flow | $3.44M | -$10.64M | -$3.06M | $2.67M | -$3.09M | +132.4% |
| End cash position | $24.79M | $21.71M | $32.42M | $35.85M | $30.23M | +14.2% |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.17 | -0.11 | +32.6% |
| Mar 2026 | -0.25 | -0.20 | +18.7% |
| Dec 2025 | -0.19 | -0.27 | -37.7% |
| Sep 2025 | -0.16 | -0.31 | -96.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.17 | 2 | $18.34M | +6.4% |
| Next quarter | -0.16 | 2 | $18.33M | +10.2% |
| Current year | -0.62 | 2 | $73.91M | +11.0% |
| Next year | -0.44 | 2 | $81.41M | +10.2% |
Analyst targets & ownership
Mean target$9.86
High target$12.00
Low target$9.00
Implied upside29.17%
Analyst count7
ConsensusSTRONG BUY
Strong buy / Buy0 / 7
Hold0
Sell / Strong sell0 / 0
Held by insiders27.83%
Held by institutions44.88%
Institutions holding75
Price targets, consensus spread, insider and institutional ownership.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 5, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Aug 5, 26 | B. Riley Securities | MAINTAINED | Buy | Buy |
| Aug 5, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jun 25, 26 | Roth Capital | INITIATED | — | Buy |
| May 12, 26 | BTIG | MAINTAINED | Buy | Buy |
| Apr 20, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Mar 11, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Mar 11, 26 | Craig-Hallum | MAINTAINED | Buy | Buy |
| Mar 11, 26 | Keybanc | MAINTAINED | Overweight | Overweight |
| Mar 10, 26 | BTIG | MAINTAINED | Buy | Buy |
| Feb 24, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Feb 17, 26 | BTIG | MAINTAINED | Buy | Buy |
Moving averages & technicals
SMA 10
6.97
+9.55% from price
SMA 20
6.16
+28.47% from price
SMA 50
5.19
+52.64% from price
SMA 100
4.37
+74.67% from price
SMA 200
4.88
+62.15% from price
EMA 12
6.88
+10.98% from price
EMA 26
6.15
+24.14% from price
EMA 50
5.48
+39.31% from price
RSI (14)
78.2
Overbought
MACD (12,26,9)
0.73
Hist 0.13
ATR (14)
0.54
6.85% of price
Realised vol 30D
109.8%
Annualised
Bollinger upper
8.46
20, 2σ
Bollinger lower
3.87
20, 2σ
50 / 200 cross
Golden
5.19 vs 4.88
Trend bias
Above 200
+62.15%
Risk profile
Beta vs SPY
2.27
More volatile than market
Correlation to SPY
0.35
Loosely linked
Realised vol 30D
109.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-77.8%
Peak to trough
Max drawdown 5Y
-90.6%
Peak to trough
ATR 14
0.54
6.85% of price
Beta (reported)
2.03
5Y monthly, from filing
SEC filings
Periodic Financial Reports
10-Q · 2026-08-04
Corporate Changes & Voting Matters
8-K · 2026-06-09
Offering Registrations
S-8 · 2026-05-12
Corporate Changes & Voting Matters
8-K · 2026-05-11
Annual Report to Shareholders
ARS · 2026-04-27
Corporate Changes & Voting Matters
8-K · 2026-04-23
Periodic Financial Reports
10-K · 2026-03-10
Corporate Changes & Voting Matters
8-K · 2026-01-12
Headlines
Exagen (XGN) Q2 2026 Earnings Call Transcript
Motley Fool · 11d ago
Exagen (XGN) Stock Gets Fair Value Boost As Analysts Weigh Growth And Execution
Simply Wall St. · 17d ago
B. Riley Adjusts Price Target on Exagen to $12 From $8, Maintains Buy Rating
MT Newswires · 17d ago
Exagen Inc. Q2 2026 Earnings Call Summary
Moby · 18d ago
Exagen Inc (XGN) (Q2 2026) Earnings Call Highlights: Record Revenue and Path to Profitability
GuruFocus.com · 18d ago
Exagen Q2 Earnings Call Highlights
MarketBeat · 18d ago
Exagen Reports Record Second-Quarter 2026 Revenue and Raises Full-Year Guidance
InvestorsHub · 18d ago
Exagen Inc. (XGN) Reports Q2 Loss, Beats Revenue Estimates
Zacks · 18d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.